Applications will open in October. Apply here!
Amount: $60,000
Sponsored by: SNMMI VI
To grow radiopharmaceutical therapies, a suitable cadre of trained physician investigators must be developed who have clinical research and care expertise in this domain. This program will develop clinical research competencies in radiopharmaceutical therapies including designing and helping conduct a clinical therapy trial. Fellow will participate in all clinical trial procedures including but not limited to attending all sponsored study meetings (study initiation, etc.), consenting patients for research protocols, interacting with the IRB (or equivalent), and conducting study procedures with study participants including histories, physicals and safety testing. Fellow will interface with academic and corporate sponsors of therapy trials and attend NCI cancer cooperative group meetings for their host institution’s group. Scientific writing skills with preparation of scientific abstracts and manuscripts will be emphasized. Clinical skills in radiopharmaceutical therapy will be honed, so that at the conclusion of the program, the fellow will be very familiar with diagnostic imaging procedures guiding therapies, patient assessment (including collecting relevant medical history, performing physical exams), patient selection, integration of other cancer therapies, and appropriate care pathways for FDA-approved molecular radiopharmaceutical therapies, and other investigational radioisotopes and molecules.
This application must be completed in its entirety and submitted along with:
Applicant's current curriculum vitae, attached to application section 'General Information'.
A research abstract and a detailed research proposal not to exceed 4 pages, excluding references, attached to application section 'Research Proposal'.
One letter of recommendation from proposed host program director/mentor, who must be a SNMMI member. Further instructions are included in the 'Letters of Recommendation' section of this application.
One letter of recommendation from a scientific or clinical mentor with direct knowledge of the candidate's work. Further instructions are included in the 'Letters of Recommendation' section of this application.
Applicant Eligibility:
Applicants will be evaluated on: